Comparing two drugs around nerves in patients with long term muscle pain.
Phase 3
- Conditions
- Health Condition 1: M638- Disorders of muscle in diseases classified elsewhere
- Registration Number
- CTRI/2023/11/059972
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosis of MFPS in the upper trapezius muscle in accordance with Simons and Travell’s essential criteria.
No treatment, including injection, dry needling, and physical modalities, in the past 3 months.
No h/o intake of NSAIDS in the past 7 days before injection.
VAS > 5
Exclusion Criteria
Bleeding tendency
History of neck and shoulder trauma
History of other disease affecting neck and shoulder pain, such as fibromyalgia, cervical radiculopathy, or adhesive capsulitis
Allergy to lignocaine
Uncontrolled diabetes mellitus
Infection at injection site
Patient refuse to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain improvement using VAS-10Timepoint: At baseline and 3 months.
- Secondary Outcome Measures
Name Time Method Quality of life using SF-12Timepoint: At baseline & 3 months.